Ledger.Open graph →
SEC Form D · Amendment · filed August 20, 2009

LIMERICK BIOPHARMA INC

Offering
$15.4M
Sold
$15.4M
Exemption
—
Industry
Biotechnology
Location
So. San Francisco, CA
Type
—

People & firms on this filing (12)

Wendye Robbins · So. San Francisco, CAExec · DirectorScott Minick · So. San Francisco, CADirectorStephen M. Dow · So. San Francisco, CADirectorChad Waite · So. San Francisco, CADirectorCorey S. Goodman · So. San Francisco, CADirectorAsha Rajagopal · So. San Francisco, CAExecStephen Kingon · Dublin, IrelandExec · DirectorAnne Maher · Dublin, IrelandExecDaniel O'Connor · Dublin, IrelandDirectorJohn O'Donnell · Dublin, IrelandDirectorSean O'Driscoll · Dublin, IrelandDirectorTed Finkelstein · Poughkeepsie, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗